You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. University scientists work to boost lifesaving cancer treatments
- 2. Lower dose of abiraterone acetate as effective for prostate cancer treatment
- 3. [Latest] Global CRISPR Gene Editing Market Size/Share Worth USD 12.6 Billion by 2034 at a 13.01% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
- 4. Predictive model based on blood cell analysis and coagulation function indicators for neuroblastic tumors staging diagnosis
- 5. NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy
- 6. Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
- 7. Thousands of cancer cases could be prevented with more breast removal surgeries
- 8. Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
- 9. B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight
- 10. The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors
Last updated at 22:20 GMT
Hot News Makers
Health/Pharma Companies
-
3840.69
-
967.00
-
584.20
-
483.80
-
480.57
-
437.21
-
432.54
-
423.33
-
393.48
-
383.56
Drugs, Treatments, Trials
-
1507.15
-
804.03
-
515.15
-
321.97
-
198.55
-
178.67
-
178.14
-
149.90
-
145.64
-
138.55
Last updated at 22:10 GMT
